A COVID-19 Overview and Potential Applications of Cell Therapy

D. Câmara, A. Porcacchia, N. Lizier, P. L. de-Sá-Júnior
{"title":"A COVID-19 Overview and Potential Applications of Cell Therapy","authors":"D. Câmara, A. Porcacchia, N. Lizier, P. L. de-Sá-Júnior","doi":"10.3390/biologics1020011","DOIUrl":null,"url":null,"abstract":"The COVID-19 pandemic has already reaped thousands of lives, although many scientific studies already showed the possibility of this scenario. Currently, further attention is provided to patients depicting comorbidities such as respiratory or immunocompromised diseases, hypertension, and diabetes, as these individuals show a worse prognosis. Cell therapies using stem cells and/or defense cells, combined or not with traditional treatment, could be an outstanding strategy for COVID-19 management since these treatments can act by modulating the immune system, reducing proliferation, and favoring the complete elimination of the virus. In this review, we highlight the main molecular characteristics of this novel coronavirus, as well as the main pathognomonic signs of COVID-19. Furthermore, possible cell therapies are pointed out to show alternative treatments against COVID-19 and its sequels.","PeriodicalId":93526,"journal":{"name":"Biologics (Basel, Switzerland)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3390/biologics1020011","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biologics (Basel, Switzerland)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/biologics1020011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

The COVID-19 pandemic has already reaped thousands of lives, although many scientific studies already showed the possibility of this scenario. Currently, further attention is provided to patients depicting comorbidities such as respiratory or immunocompromised diseases, hypertension, and diabetes, as these individuals show a worse prognosis. Cell therapies using stem cells and/or defense cells, combined or not with traditional treatment, could be an outstanding strategy for COVID-19 management since these treatments can act by modulating the immune system, reducing proliferation, and favoring the complete elimination of the virus. In this review, we highlight the main molecular characteristics of this novel coronavirus, as well as the main pathognomonic signs of COVID-19. Furthermore, possible cell therapies are pointed out to show alternative treatments against COVID-19 and its sequels.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
COVID-19细胞治疗综述及潜在应用
新冠肺炎大流行已经夺走了数千人的生命,尽管许多科学研究已经表明了这种情况的可能性。目前,人们进一步关注患有呼吸道或免疫功能低下疾病、高血压和糖尿病等合并症的患者,因为这些患者的预后较差。使用干细胞和/或防御细胞的细胞疗法,无论是否与传统治疗相结合,都可能是新冠肺炎治疗的杰出策略,因为这些治疗可以通过调节免疫系统、减少增殖和有利于完全消除病毒来发挥作用。在这篇综述中,我们强调了这种新型冠状病毒的主要分子特征,以及新冠肺炎的主要病理特征。此外,还指出了可能的细胞疗法,以显示针对新冠肺炎及其后续疾病的替代疗法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The Role of Anti-DFS70 in the Diagnosis of Systemic Autoimmune Rheumatic Diseases Is Metagenomics the Future Routine Diagnosis Tool for Brain Abscesses? About a Case Neoantigens: The Novel Precision Cancer Immunotherapy Dose-Dependency of the Glycemic Response to Polyphenol-Rich Sugarcane Extract (PRSE) Robust Porcine GFR Measurement with Radiotracers and Only Late Blood Samples
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1